McDonald KL - Search Results

1

TP53 Mutation Is a Prognostic Factor in Lower Grade Glioma and May Influence Chemotherapy Efficacy.

Noor H, Briggs NE, McDonald KL, Holst J, Vittorio O. Noor H, et al. Among authors: mcdonald kl. Cancers (Basel). 2021 Oct 26;13(21):5362. doi: 10.3390/cancers13215362. Cancers (Basel). 2021. PMID: 34771529 Free PMC article.

2

DLL3 expression and methylation are associated with lower-grade glioma immune microenvironment and prognosis.

Noor H, Whittaker S, McDonald KL. Noor H, et al. Among authors: mcdonald kl. Genomics. 2022 Mar;114(2):110289. doi: 10.1016/j.ygeno.2022.110289. Epub 2022 Feb 4. Genomics. 2022. PMID: 35124175 Free article.

3

Association Between IDH1 and IDH2 Mutations and Preoperative Seizures in Patients with Low-Grade Versus High-Grade Glioma: A Systematic Review and Meta-Analysis.

Phan K, Ng W, Lu VM, McDonald KL, Fairhall J, Reddy R, Wilson P. Phan K, et al. Among authors: mcdonald kl. World Neurosurg. 2018 Mar;111:e539-e545. doi: 10.1016/j.wneu.2017.12.112. Epub 2017 Dec 27. World Neurosurg. 2018. PMID: 29288860 Review.

4

Isocitrate dehydrogenase 1 mutation subtypes at site 132 and their translational potential in glioma.

Lu VM, McDonald KL. Lu VM, et al. Among authors: mcdonald kl. CNS Oncol. 2018 Jan;7(1):41-50. doi: 10.2217/cns-2017-0019. Epub 2018 Jan 5. CNS Oncol. 2018. PMID: 29303363 Free PMC article.

5

The role of TP53 gain-of-function mutation in multifocal glioblastoma.

Olafson LR, Gunawardena M, Nixdorf S, McDonald KL, Rapkins RW. Olafson LR, et al. Among authors: mcdonald kl. J Neurooncol. 2020 Mar;147(1):37-47. doi: 10.1007/s11060-019-03318-5. Epub 2020 Jan 30. J Neurooncol. 2020. PMID: 32002804 Free PMC article.

6

PathoFusion: An Open-Source AI Framework for Recognition of Pathomorphological Features and Mapping of Immunohistochemical Data.

Bao G, Wang X, Xu R, Loh C, Adeyinka OD, Pieris DA, Cherepanoff S, Gracie G, Lee M, McDonald KL, Nowak AK, Banati R, Buckland ME, Graeber MB. Bao G, et al. Among authors: mcdonald kl. Cancers (Basel). 2021 Feb 4;13(4):617. doi: 10.3390/cancers13040617. Cancers (Basel). 2021. PMID: 33557152 Free PMC article.

7

The MGMT promoter SNP rs16906252 is a risk factor for MGMT methylation in glioblastoma and is predictive of response to temozolomide.

Rapkins RW, Wang F, Nguyen HN, Cloughesy TF, Lai A, Ha W, Nowak AK, Hitchins MP, McDonald KL. Rapkins RW, et al. Among authors: mcdonald kl. Neuro Oncol. 2015 Dec;17(12):1589-98. doi: 10.1093/neuonc/nov064. Epub 2015 Apr 24. Neuro Oncol. 2015. PMID: 25910840 Free PMC article.

8

Somatic mutations in glioblastoma are associated with methylguanine-DNA methyltransferase methylation.

McDonald KL, Tabone T, Nowak AK, Erber WN. McDonald KL, et al. Oncol Lett. 2015 May;9(5):2063-2067. doi: 10.3892/ol.2015.2980. Epub 2015 Feb 20. Oncol Lett. 2015. PMID: 26137013 Free PMC article.

9

Veliparib in combination with radiotherapy for the treatment of MGMT unmethylated glioblastoma.

Jue TR, Nozue K, Lester AJ, Joshi S, Schroder LB, Whittaker SP, Nixdorf S, Rapkins RW, Khasraw M, McDonald KL. Jue TR, et al. Among authors: mcdonald kl. J Transl Med. 2017 Mar 17;15(1):61. doi: 10.1186/s12967-017-1164-1. J Transl Med. 2017. PMID: 28314386 Free PMC article.

10

Cyclin-dependent kinase 7 is a therapeutic target in high-grade glioma.

Greenall SA, Lim YC, Mitchell CB, Ensbey KS, Stringer BW, Wilding AL, O'Neill GM, McDonald KL, Gough DJ, Day BW, Johns TG. Greenall SA, et al. Among authors: mcdonald kl. Oncogenesis. 2017 May 15;6(5):e336. doi: 10.1038/oncsis.2017.33. Oncogenesis. 2017. PMID: 28504693 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

195 results

Search Page